These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3225604)

  • 1. Cerebral venous thrombosis as presenting sign of myeloproliferative disorders.
    Haan J; Caekebeke JF; van der Meer FJ; Wintzen AR
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1219-20. PubMed ID: 3225604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic parameters in polycythaemia vera rubra. Correlations of clinical and histomorphological features in 60 patients.
    Zankovich R; Thiele J; Fiessler WD; Fischer R; Diehl V
    Med Klin (Munich); 1987 Dec; 82(25-26):889-94, 927. PubMed ID: 3437853
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Bächli E; Gundelfinger M
    Praxis (Bern 1994); 2017 Jul; 106(15):807-813. PubMed ID: 28745110
    [No Abstract]   [Full Text] [Related]  

  • 6. Aseptic cerebral venous thrombosis associated with idiopathic ulcerative colitis: a report of two cases.
    Das R; Vasishta RK; Banerjee AK
    Clin Neurol Neurosurg; 1996 May; 98(2):179-82. PubMed ID: 8836595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
    Seewann HL
    Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelofibrosis in the myeloproliferative disorders.
    Ellis JT; Peterson P
    Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J; Kvasnicka HM; Vardiman J
    Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract]   [Full Text] [Related]  

  • 11. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
    Tovar-Bobadilla JL; Ortiz-Hidalgo C
    Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vascular changes in bone marrow in blood diseases].
    Demmler K; Burkhardt R
    Med Klin; 1980 Apr; 75(9):328-32. PubMed ID: 7402170
    [No Abstract]   [Full Text] [Related]  

  • 13. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic myeloproliferative diseases].
    Verh Dtsch Ges Pathol; 1983; 67():214-75. PubMed ID: 6666266
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.
    Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
    J Clin Pathol; 1986 Mar; 39(3):237-52. PubMed ID: 3457024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of interferon in the treatment of chronic myeloproliferative disorders].
    Robak T
    Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
    Campr V
    Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent deep vein thrombosis and myeloproliferative syndrom: emergence of JAK2 mutation five years after the initial event].
    Salort A; Seinturier C; Molina L; Lévèque P; Imbert B; Pernod G
    J Mal Vasc; 2014 May; 39(3):207-11. PubMed ID: 24721000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.